SuperworthBio-Rad Laboratories shares outstanding BIO
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 26.8M
- On a year earlier
- −1.5%
- fewer shares
Bio-Rad Laboratories had 26.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 27M | −4% |
| FY2024 | 28M | −3% |
| FY2023 | 28.8M | −3% |
| FY2022 | 29.7M | −1% |
| FY2021 | 29.9M | −1% |
| FY2020 | 30.2M | −0% |
| FY2019 | 30.3M | +1% |
| FY2018 | 29.9M | −1% |
| FY2017 | 30.2M | +2% |
| FY2016 | 29.6M | +0% |
| FY2015 | 29.5M | +1% |
| FY2014 | 29.2M | +1% |
| FY2013 | 29M | +1% |
| FY2012 | 28.7M | +1% |
| FY2011 | 28.5M | +1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 26.8M | −2% | |
| Q1 FY26 | 27M | −4% | |
| Q4 FY25 | 27M | −4% | |
| Q3 FY25 | 26.9M | −4% | |
| Q2 FY25 | 27.2M | −4% | |
| Q1 FY25 | 28M | −2% | |
| Q4 FY24 | 28M | −3% | |
| Q3 FY24 | 28M | −4% | |
| Q2 FY24 | 28.4M | −3% | |
| Q1 FY24 | 28.5M | −4% | |
| Q4 FY23 | 28.8M | −3% | |
| Q3 FY23 | 29.2M | −2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Bio-Rad Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.